Foundation Fighting Blindness Retinal Degeneration Fund

IRD

Foundation Fighting Blindness Retinal Degeneration Fund serves as director, other: See Remarks at Opus Genetics, Inc. (IRD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$15.99M

Net Position

Net Seller

$15.99M

Companies Traded

IRD

Active Period

Dec 2025 – May 2026

2 total trades

Most Recent

Sell IRD

May 20, 2026 · $7.39M

Foundation Fighting Blindness Retinal Degeneration Fund's Insider Trading at Opus Genetics, Inc. (IRD)

Buys

0 · $0.00

Sells

2 · $15.99M

Total Shares Bought

Total Shares Sold

5,700,000

IRD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 20, 2026	Sell	1,700,000	$4.35	$7.39M	3,792,171
Dec 11, 2025	Sell	4,000,000	$2.15	$8.60M	5,492,171

Related Insiders

George Magrath

director, officer: Chief Executive Officer

IRDSell · Apr 27, 2026

Rabourn Amy Zaremba

officer: Head of Fin. Quality Assurance

IRDSell · Apr 27, 2026

Ashwath Jayagopal

officer: Chief Scientific & Dev. Ofc.

IRDSell · Apr 27, 2026

Robert E. Gagnon

officer: Chief Financial Officer

IRDSell · Apr 27, 2026

SCHACHLE JOSEPH K

officer: Chief Operating Officer

IRDSell · Apr 27, 2026

YERXA BENJAMIN R

director, officer: President

IRDSell · Apr 27, 2026

Cam Gallagher

IRDBuy · Dec 31, 2025

Explore More Insider Trading Data

IRD Insider Trading Activity

View all insider trades at Opus Genetics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity